Kevin Ariën

Medicine & Life Sciences

1. SARS Virus 100%
2. Anti-Infective Agents 90%
3. HIV-1 79%
4. Chikungunya virus 69%
5. HIV 66%
6. Reverse Transcriptase Inhibitors 62%
7. Viruses 58%
8. Belgium 49%
9. Disease Outbreaks 47%
10. Zika Virus 44%
11. Democratic Republic of the Congo 44%
12. Coronavirus 40%
13. Dapivirine 39%
14. Neutralizing Antibodies 38%
15. Vaccination 37%
16. Alphavirus 35%
17. Antibodies 32%
18. Infection 32%
19. Vaccines 28%
20. Severe Acute Respiratory Syndrome 27%
21. In Vitro Techniques 25%
22. Aruba 25%
23. Messenger RNA 25%
24. Routine Diagnostic Tests 24%
25. Neutralization Tests 23%
26. Chikungunya Fever 21%
27. Arboviruses 21%
28. Culicidae 21%
29. Dengue 20%
30. Ebolavirus 20%
31. Genitalia 20%
32. Immunoglobulin G 19%
33. Antigens 19%
34. Triazines 18%
35. Genotype 18%
36. Dengue Virus 18%
37. Gels 18%
38. Health Personnel 17%
39. Antiviral Agents 17%
40. T-Lymphocytes 17%
41. Mutation 16%
42. Female Genitalia 16%
43. Humoral Immunity 16%
44. Antibody Formation 15%
45. RNA 15%
46. Serologic Tests 14%
47. Ebola Hemorrhagic Fever 14%
48. Cohort Studies 14%
49. Anti-HIV Agents 13%
50. Foams and Jellies Vaginal Creams 13%